Click image to enlarge
The Human Bone Marker Panel II Kit provides assay-specific components for the quantitative determination of both natural and recombinant human osteocalcin (OCL), osteonectin (ONN), and osteopontin (OPN) in serum and plasma.
-
-
Specifications
-
-
Documentation
-
References
Application(s)
|
|
Bone Disorders
|
|
Analyte(s)
|
|
Osteocalcin, Osteonectin, Osteopontin
|
|
Species
|
|
Human
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO SECTOR S 600MM
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120MM
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
|
|
Plate Type
|
|
96-well
|
|
Capture Antibody
|
|
Osteocalcin: Mouse Monoclonal Osteonectin: Goat Polyclonal Osteopontin: Goat Polyclonal
|
|
Detection Antibody
|
|
Osteocalcin: Mouse Monoclonal Osteonectin: Mouse Monoclonal Osteopontin: Goat Polyclonal
|
|
LLOD (Sensitivity)
|
|
Osteocalcin: 0.023 ng/mL Osteonectin: 2.6 ng/mL Osteopontin: 0.05 ng/mL
|
|
Dynamic Range
|
|
Osteocalcin: 0.023 - 200 ng/mL Osteonectin: 2.6 - 2000 ng/mL Osteopontin: 0.05 - 200 ng/mL
|
|
Sample Type
|
|
Serum, Plasma
|
|
Recombinant standards
|
|
Osteocalcin: Synthetic Human Osteocalcin (aa1-49) Osteonectin: Protein isolated from thrombin-activated human platelets Osteopontin: Recombinant human osteopontin, his-tagged
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
Storage Condition
|
|
Multi-Component
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Inserts
|
|
|
Datasheets
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
|
|
|
|
Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes.
|
|
|
|
Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats.
|
|
|
|
Assessment of cisplatin-induced kidney injury using an integrated rodent platform.
|
|
|
|
Early prediction of polymyxin-induced nephrotoxicity with next generation urinary kidney injury biomarkers.
|
|
|
|
View All
|
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters